• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《脑脊液中tau蛋白与肽的比率用于改善阿尔茨海默病诊断分类》的勘误 [临床质谱学。14 (B部分) (2019) 74 - 82]

Corrigendum to "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease" [Clin. Mass Spectrom. 14 (Part B) (2019) 74-82].

作者信息

Hansson Karl, Dahlén Rahil, Hansson Oskar, Pernevik Elin, Paterson Ross, Schott Jonathan M, Magdalinou Nadia, Zetterberg Henrik, Blennow Kaj, Gobom Johan

机构信息

Institute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.

Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

出版信息

J Mass Spectrom Adv Clin Lab. 2022 Sep 28;26:35. doi: 10.1016/j.jmsacl.2022.08.002. eCollection 2022 Nov.

DOI:10.1016/j.jmsacl.2022.08.002
PMID:36187744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9523399/
Abstract

[This corrects the article DOI: 10.1016/j.clinms.2019.07.002.].

摘要

[本文更正了文章的数字对象标识符：10.1016/j.clinms.2019.07.002。]

相似文献

1
Corrigendum to "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease" [Clin. Mass Spectrom. 14 (Part B) (2019) 74-82].《脑脊液中tau蛋白与肽的比率用于改善阿尔茨海默病诊断分类》的勘误 [临床质谱学。14 (B部分) (2019) 74 - 82]
J Mass Spectrom Adv Clin Lab. 2022 Sep 28;26:35. doi: 10.1016/j.jmsacl.2022.08.002. eCollection 2022 Nov.
2
Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45].《抗结核药物治疗药物监测的质谱分析》勘误[临床质谱学14（A部分）（2019年）34 - 45页]
J Mass Spectrom Adv Clin Lab. 2022 Aug 13;25:72. doi: 10.1016/j.jmsacl.2022.08.001. eCollection 2022 Aug.
3
Corrigendum to "Analytical validation of protein biomarkers for risk of spontaneous preterm birth" [Clin. Mass Spectrom. 3 (2017) 25-38].《自发性早产风险蛋白质生物标志物的分析验证》[临床质谱学3（2017）25 - 38]的勘误
J Mass Spectrom Adv Clin Lab. 2022 Aug 9;25:71. doi: 10.1016/j.jmsacl.2022.07.007. eCollection 2022 Aug.
4
Corrigendum to "Instability of 7-aminoclonazepam in frozen storage conditions" [Clin. Mass Spectrom. 9 (2018) 23-24].《“7-氨基氯硝西泮在冷冻储存条件下的不稳定性”勘误》[《临床质谱学》9(2018)23 - 24]
J Mass Spectrom Adv Clin Lab. 2022 Sep 24;26:34. doi: 10.1016/j.jmsacl.2022.09.006. eCollection 2022 Nov.
5
Corrigendum to "Observation of a positive interference in LC-MS/MS measurement of d6-25-OH-vitamin D3" [Clin. Mass Spectrom. 3 (2017) 22-24].《“d6 - 25 - 羟基维生素D3的液相色谱 - 串联质谱测定中的正干扰观察”勘误》[临床质谱学 3 (2017) 22 - 24]
J Mass Spectrom Adv Clin Lab. 2022 Sep 9;26:20. doi: 10.1016/j.jmsacl.2022.09.002. eCollection 2022 Nov.
6
Corrigendum to "Manipulating trypsin digestion conditions to accelerate proteolysis and simplify digestion workflows in development of protein mass spectrometric assays for the clinical laboratory" [Clin. Mass Spectrom. 6C (2018) 1-12].《“在临床实验室蛋白质质谱分析方法开发中操控胰蛋白酶消化条件以加速蛋白水解并简化消化工作流程”的勘误》[临床质谱学 6C（2018 年）1 - 12]
Clin Mass Spectrom. 2018 Aug 30;10:33-34. doi: 10.1016/j.clinms.2018.08.005. eCollection 2018 Dec.
7
Corrigendum to "Migration from RIA to LC-MS/MS for aldosterone determination: Implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects" [Clin. Mass Spectrom. 9 (2018) 7-17].《从放射免疫分析迁移至液相色谱-串联质谱法测定醛固酮：对临床实践的影响以及一组健康比利时受试者血浆和尿液参考范围区间的测定》勘误 [临床质谱学 9 (2018) 7 - 17]
J Mass Spectrom Adv Clin Lab. 2022 Oct 26;26:47. doi: 10.1016/j.jmsacl.2022.10.001. eCollection 2022 Nov.
8
Corrigendum to "Development and validation of a multiplexed LC-MS/MS ketone body assay for clinical diagnostics" [J. Mass Spectrom. Adv. Clin. Lab 31 (2024) 49-58].《用于临床诊断的多重液相色谱-串联质谱酮体检测方法的开发与验证》的勘误 [《质谱学报：临床实验室进展》31 (2024) 49 - 58]
J Mass Spectrom Adv Clin Lab. 2024 Jul 17;33:21. doi: 10.1016/j.jmsacl.2024.07.001. eCollection 2024 Aug.
9
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease.使用脑脊液中tau蛋白与肽的比率来改善阿尔茨海默病的诊断分类。
Clin Mass Spectrom. 2019 Jul 15;14 Pt B:74-82. doi: 10.1016/j.clinms.2019.07.002. eCollection 2019 Nov.
10
Erratum regarding missing Declaration of Competing Interest Statements in previously published articles.关于之前发表文章中缺失利益冲突声明的勘误。
J Mass Spectrom Adv Clin Lab. 2021 Jan 29;20:48. doi: 10.1016/j.jmsacl.2021.01.001. eCollection 2021 Apr.